Catalyst Wire Dossier Catalyst Wire Dossier

177Lu-PSMA small molecule

Lutetium-177 labeled PSMA-targeted small molecule
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-PSMA small molecule, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer [Phase 1]

See pricing